This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal

Follow-Up Anoka Schizophrenic Cohort, 1956-1958

DONALD B. PETERSON, MD; GORDON W. OLSON, PhD

Arch Gen Psychiatry. 1964;11(2):137-144.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

There remains little doubt today of the therapeutic effectiveness of the ataractic drugs in the treatment of the acute schizophrenic. However, their long-range effectiveness is less well established. Predictions concerning the projected effect vary from a reduction of 25% among the chronically ill to abolition of the large state hospitals. The question then arises as to the permanence or impermanence of the advantages these drugs offer the schizophrenic—namely, whether a change has occurred in the percentage who eventually become chronic.

Also, more up to date information concerning the probability of release and readmission is needed to enable the patient, the doctor, the hospital, and the government to formulate realistic plans for the future. It would be valuable to be able to cite with some accuracy the probability of release for the newly admitted patient, the probable length of stay and the likelihood of remaining . . . [Full Text PDF of this Article]

Author Affiliations
FULTON, MO; ANOKA, MINN

Superintendent (Dr. Peterson), State Hospital No. 1; formerly Superintendent, Anoka State Hospital, Anoka, Minn; Chief Psychologist (Dr. Olson), Anoka State Hospital.

Footnotes
Submitted for publication Dec 13, 1963.

Read before the 119th Annual Meeting of the American Psychiatric Association, St. Louis, Mo, May 6-10, 1963.